Search research articles
Contact Us
Filters
Showing results (711-720 of 737) with videos related to
Page
of 74
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2020
SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study
Jillian H Hurst, Sarah M Heston, Hailey N Chambers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2025
Ziftomenib in Relapsed or Refractory <i>NPM1</i>-Mutated AML
Eunice S Wang, Pau Montesinos, James Foran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study
Jillian H Hurst, Sarah M Heston, Hailey N Chambers, et al.
Nature Communications
|
November 30, 2023
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
A Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
Free Radical Biology & Medicine
|
February 22, 2005
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
M B Kadiiska, B C Gladen, D D Baird, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes
Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
The New England Journal of Medicine
|
February 15, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age
Flor M Muñoz, Lawrence D Sher, Charu Sabharwal, et al.
Plos One
|
November 1, 2011
H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination
M Anthony Moody, Ruijun Zhang, Emmanuel B Walter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
Angela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
The Lancet. Infectious Diseases
|
October 22, 2019
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I Bernstein, Jeffrey Guptill, Abdollah Naficy, et al.
Page
of 74
Search research articles
Search
Showing results (711-720 of 737) with videos related to
Sort By:
Page
of 74
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2020
SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study
Jillian H Hurst, Sarah M Heston, Hailey N Chambers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2025
Ziftomenib in Relapsed or Refractory <i>NPM1</i>-Mutated AML
Eunice S Wang, Pau Montesinos, James Foran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study
Jillian H Hurst, Sarah M Heston, Hailey N Chambers, et al.
Nature Communications
|
November 30, 2023
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
A Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
Free Radical Biology & Medicine
|
February 22, 2005
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
M B Kadiiska, B C Gladen, D D Baird, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes
Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
The New England Journal of Medicine
|
February 15, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age
Flor M Muñoz, Lawrence D Sher, Charu Sabharwal, et al.
Plos One
|
November 1, 2011
H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination
M Anthony Moody, Ruijun Zhang, Emmanuel B Walter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2023
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
Angela R Branche, Nadine G Rouphael, Cecilia Losada, et al.
The Lancet. Infectious Diseases
|
October 22, 2019
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I Bernstein, Jeffrey Guptill, Abdollah Naficy, et al.
Page
of 74